CYCLOPHOSPHAMIDE FOR , USP for Bone marrow conditioning regimen: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where CYCLOPHOSPHAMIDE FOR , USP was used for Bone marrow conditioning regimen.
Most Reported Side Effects for CYCLOPHOSPHAMIDE FOR , USP
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 73 | 20.1% | 73 | 1 |
| Neoplasm progression | 62 | 17.1% | 62 | 0 |
| Disease progression | 39 | 10.7% | 6 | 0 |
| Neutropenia | 32 | 8.8% | 21 | 0 |
| Thrombocytopenia | 23 | 6.3% | 22 | 0 |
| Exposure during pregnancy | 21 | 5.8% | 0 | 0 |
| Acute graft versus host disease | 20 | 5.5% | 0 | 0 |
| Leukaemia recurrent | 18 | 5.0% | 18 | 0 |
| Disease recurrence | 16 | 4.4% | 13 | 0 |
| No adverse event | 15 | 4.1% | 0 | 0 |
| Liver function test abnormal | 7 | 1.9% | 0 | 0 |
| Precursor t-lymphoblastic lymphoma/leukaemia recurrent | 6 | 1.7% | 0 | 0 |
| Bacteraemia | 5 | 1.4% | 0 | 0 |
| Chronic graft versus host disease | 5 | 1.4% | 0 | 0 |
| Dehydration | 5 | 1.4% | 0 | 4 |
Other Indications for CYCLOPHOSPHAMIDE FOR , USP
Breast cancer (98)
Acute leukaemia (25)
Prophylaxis against graft versus host disease (25)
Blast crisis in myelogenous leukaemia (21)
Mantle cell lymphoma (21)
Leukaemia (18)
B-cell lymphoma (15)
Plasma cell myeloma (14)
Acute lymphocytic leukaemia (12)
Diffuse large b-cell lymphoma (12)
Other Drugs Used for Bone marrow conditioning regimen
FLUDARABINE (6,080)
BUSULFAN (4,669)
CYCLOPHOSPHAMIDE (4,485)
MELPHALAN (2,368)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884)
THIOTEPA (1,551)
ALEMTUZUMAB (1,122)
ETOPOSIDE (936)
CYTARABINE (833)
THYMOCYTE IMMUNE GLOBULIN NOS (742)